Clinical Trial

PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter, open-label, randomized controlled trial to investigate whether a linear ablation in addition to pulmonary vein isolation (PVI) outperforms PVI alone using pulsed field ablation (PFA) in maintaining sinus rhythm for persistent atrial fibrillation (PerAF)
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2025-08-05; most recent amendment 2026-06-16.
Status change: Not Yet Recruiting → Recruiting 2025-09-01
Trial Details
NCT Number NCT07106970
Lead Sponsor Boston Scientific Corporation
Conditions Persistent Atrial Fibrillation
Enrollment 640 participants
Start Date 2025-08-28
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-03